Ideas & Insights

SPACs have grown in popularity recently as a means of going public. Learn why high-growth companies are using this method.

RSM senior industry analyst Adam Lohr shares the latest on deals, going public and more in the biotech, pharma and medical devices sectors.

Missed our recent webcast on how the Tax Cuts and Jobs Act will affect life sciences companies? Check out our recap.

As your life sciences company expands globally, compliance with the FCPA becomes a business imperative for your organization. Learn more.

A comprehensive contract compliance audit should be completed on existing contracts to ensure optimal compliance.

As your life sciences company expands globally, compliance with the FCPA becomes a business imperative for your organization. Learn more.

Watch the video from RSM’s Technology Experience Center to learn about the technology trends affecting life sciences companies.